Company Profile:

Founded in 1995 by Drs. Joseph Brown and Glenna Burmer, LSBio (LifeSpan BioSciences, Inc.) was established as a molecular pathology company with a focus on protein localization in human diseased tissues by immunohistochemistry (IHC). Through the experience gained by executing thousands of IHC studies, and generating and testing many thousands of antibodies, LSBio has become a world leader in the antibody industry, with a reputation for excellence.

LSBio's product catalog includes 82,900 monoclonal and polyclonal antibodies to 13,000 targets. Antibodies are available for most species and all major research applications, such as immunoblotting, immunohistochemistry, immunofluorescence, and fluorescence-activated cell sorting. Through extensive ongoing in-house testing, more than 3,500 of these antibodies have also been identified as exceptional immunohistochemistry reagents, and given the IHC-plusTM brand.

More than 1,000 tissue microarrays are also available through LSBio, providing researchers with a cost-effective and time-saving resource for researching protein localization and expression in all major normal human tissue types and cancers.

For more than a decade researchers have been relying upon LSBio's expertise to fulfill their molecular pathology outsourcing needs. LSBio's services include: antibody production and characterization, custom immunohistochemistry studies supported by a massive archival human tissue bank, tissue cross-reactivity screening, and standard histology procedures and pathology analysis.

LSBio stands behind the quality of its products and services and offers unparalleled customer service and support. In the years to come, LSBio plans to continue expanding its catalog of high-quality proteomics products, with a focus on IHC-validated antibodies, providing its customers with excellent reagents, services, and support to accelerate their research.